Clinical trials
Terminated Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
231 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 5 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 9 |
| 2014 | 4 |
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 15 |
| 2018 | 14 |
| 2019 | 17 |
| 2020 | 20 |
| 2021 | 37 |
| 2022 | 32 |
| 2023 | 21 |
| 2024 | 16 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 231 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 13 |
| Fudan University | 11 |
| Jiangsu HengRui Medicine Co., Ltd. | 11 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 9 |
| Novartis Pharmaceuticals | 8 |
| Sanofi | 6 |
| Boehringer Ingelheim | 5 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 5 |
| Shanghai Jiao Tong University School of Medicine | 5 |
| Arrowhead Pharmaceuticals | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 15 |
| Breast Neoplasms | 13 |
| Stomach Neoplasms | 10 |
| Triple Negative Breast Neoplasms | 7 |
| Colorectal Neoplasms | 6 |
| Hepatitis B, Chronic | 6 |
| Carcinoma, Hepatocellular | 5 |
| Hepatitis B | 5 |
| Arthritis | 4 |
| Arthritis, Rheumatoid | 4 |
Trials
Showing 1 to 25 of 231. Each trial links to its page on Pharma Observatory.
131 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.